General
| Peptide: | KSL |
| Microorganism: | Streptococcus mutans ATCC 25175 |
| Administration: | |
| Stage: | Formation (3-24h) |
| Notes: |
Experimental procedure
| Method | AMP Effect(Biofilm reduction) | Concentration | Notes |
|---|---|---|---|
| Crystal violet assay | 21 - 50% | 50.007 uM | |
| Crystal violet assay | 51 - 90% | 100.013 uM | |
| Crystal violet assay | > 90% | 400.054 uM | |
| Crystal violet assay | Not Active | 12.482 uM | |
| Crystal violet assay | <= 20 % | 25.003 uM |
Reference
- Yi Liu, Lina Wang, Xuedong Zhou, Shen Hu, Siyu Zhang, Hongkun Wu Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm
M. Di Luca, G. Maccari, G. Maisetta, G. Batoni BaAMPs: the database of biofilm-active antimicrobial peptides Biofouling 2015; 31(2):193-9.
Please do not hesitate to address comments or questions to: mariagrazia.diluca@nano.cnr.it or gpmaccari@gmail.com